# Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

> **NCT01220583** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Radiation Therapy Oncology Group** · enrollment: 252 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT01220583
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-01
- **Primary completion:** 2026-10-31
- **Final completion:** 2028-10
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220583, "Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01220583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*